Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Capricor Therapeutics (CAPR) Assets Average (2016 - 2025)

Capricor Therapeutics (CAPR) has 15 years of Assets Average data on record, last reported at $130.0 million in Q3 2025.

  • For Q3 2025, Assets Average rose 98.13% year-over-year to $130.0 million; the TTM value through Sep 2025 reached $130.0 million, up 98.13%, while the annual FY2024 figure was $114.6 million, 110.62% up from the prior year.
  • Assets Average reached $130.0 million in Q3 2025 per CAPR's latest filing, down from $143.7 million in the prior quarter.
  • Across five years, Assets Average topped out at $162.1 million in Q1 2025 and bottomed at $39.1 million in Q1 2021.
  • Average Assets Average over 5 years is $68.9 million, with a median of $52.0 million recorded in 2022.
  • Peak YoY movement for Assets Average: decreased 25.74% in 2023, then skyrocketed 227.55% in 2025.
  • A 5-year view of Assets Average shows it stood at $42.2 million in 2021, then grew by 23.2% to $52.0 million in 2022, then decreased by 7.82% to $47.9 million in 2023, then surged by 174.73% to $131.7 million in 2024, then dropped by 1.3% to $130.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Assets Average were $130.0 million in Q3 2025, $143.7 million in Q2 2025, and $162.1 million in Q1 2025.